i2O Therapeutics (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- April 09, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $4,000,000
Company Info
- Founders
- Samir Mitragotri, PhD
- Company Description
- i2O Therapeutics is a biotechnology company developing safe and effective oral formulations of therapies traditionally limited to injections. Using an innovative ionic liquid technology, this platform leverages the benefits of protecting the drug cargo while also transiently enhancing permeation across the epithelial lining when administered orally.
- Market
- Oral peptide and protein-based therapies
- Location
- Allston, MA, USA
- Coinvestors
- JDRF T1D Fund, Sanofi Ventures